Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Bicycle Therapeutics

    - PMLiVE

    Lilly and WHO Foundation partner to support global dementia action plan

    The partnership will provide financial support and strengthen early detection and intervention efforts

    - PMLiVE

    Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities

    Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...

    Medscape Education

    - PMLiVE

    Lilly launches global Alzheimer’s campaign with Julianne Moore

    The new ‘Brain Health Matters’ campaign urges the public to prioritise brain health

    - PMLiVE

    AbbVie and ADARx enter multi-billion dollar partnership to develop siRNA therapies

    The companies will focus on developing therapeutics across neuroscience, immunology and oncology

    - PMLiVE

    GSK to explore link between Shingrix and dementia risk in new UK research collaboration

    More than 55 million people worldwide are currently living with the neurodegenerative disease

    - PMLiVE

    UK drug repurposing study identifies several potential dementia treatments

    An estimated 982,000 people in the UK are currently living with the neurodegenerative disease

    - PMLiVE

    J&J expands neuroscience capabilities with $14.6bn Intra-Cellular acquisition

    The deal gives the company access to a range of central nervous system disorder drugs

    - PMLiVE

    Novartis and Schrödinger to advance drug candidates in deal worth over $2.4bn

    The companies will advance therapeutics for undisclosed targets in Novartis’ core areas

    - PMLiVE

    AbbVie to expand neuroscience pipeline with $1.4bn Aliada Therapeutics acquisition

    The deal includes a candidate in phase 1 development for Alzheimer's disease

    - PMLiVE

    Eli Lilly shares positive results for modified titration of Alzheimer’s drug donanemab

    The neurodegenerative disorder accounts for up to 75% of the 982,000 dementia cases in the UK

    - PMLiVE

    Astellas and AviadoBio enter exclusive dementia gene therapy deal worth over $2bn

    Frontotemporal dementia accounts for less than one in 30 cases of the neurodegenerative disorder

    Bayer symbol

    Bayer and NextRNA Therapeutics enter oncology partnership worth $547m

    The companies will advance small molecule therapeutics against a new class of targets for cancer

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links